GLP-1 Pipeline Update: May 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
Here we highlight data informing the safety, efficacy, and potential utility of new and emerging glucagon-like peptide-1 medicines
It requires adjusting the amount per injection, recalculating your syringe measurements , and monitoring for any changes in side effects or efficacy
Consult your healthcare provider to monitor and adjust medication as your weight changes
Whether youre looking for subtle enhancements or post-trauma reconstruction, were here to guide you every step of the way